Compositions and methods for treating viral infection are disclosed. The compositions contain a combination of zinc and a cyclo(His-Pro), in effective amounts. The composition containing a combination of zinc and a cyclo(His-Pro) can be used to treat viral infections including SARS-CoV-2 infections in mammals.

Compositions and methods for treating viral infection are disclosed. The compositions contain a combination of zinc and a cyclo(His-Pro), in effective amounts. The composition containing a combination of zinc and a cyclo(His-Pro) can be used to treat viral infections including SARS-CoV-2 infections in mammals.

The disclosure provides pharmaceutical formulations of the compound of Formula I:

##STR00001##

or a pharmaceutically acceptable salt thereof.

The disclosure provides pharmaceutical formulations of the compound of Formula I:

##STR00001##

or a pharmaceutically acceptable salt thereof.

Embodiments of a method and supplement for preventing and/or treating gastrointestinal distress, including ulcer conditions, in animals such as humans are disclosed. The supplement is in a tablet or capsule form and comprises mastic gum and an emulsifying agent such as lecithin. The supplement may also comprise B vitamins, one or more prebiotics or probiotics, and one or more minerals as well as, pH buffers and flavoring. A disclosed method of preventing and/or treating gastrointestinal distress comprises orally dosing an animal such as a human with the supplement at least once daily.

Embodiments of a method and supplement for preventing and/or treating gastrointestinal distress, including ulcer conditions, in animals such as humans are disclosed. The supplement is in a tablet or capsule form and comprises mastic gum and an emulsifying agent such as lecithin. The supplement may also comprise B vitamins, one or more prebiotics or probiotics, and one or more minerals as well as, pH buffers and flavoring. A disclosed method of preventing and/or treating gastrointestinal distress comprises orally dosing an animal such as a human with the supplement at least once daily.

This invention relates to clear one-phase liquid formulation vehicles comprising lecithin, MCT, bile salt and water.

This invention relates to clear one-phase liquid formulation vehicles comprising lecithin, MCT, bile salt and water.

The present invention provides Phosphatidylserine (PS) preparations with PS having a predetermined particle size for use in sports nutrition and/or promoting skin health in a subject. The methods of the present invention include administering a daily dose of the PS preparation to improve sports performance and/or promote skin health in a subject.

The present invention provides Phosphatidylserine (PS) preparations with PS having a predetermined particle size for use in sports nutrition and/or promoting skin health in a subject. The methods of the present invention include administering a daily dose of the PS preparation to improve sports performance and/or promote skin health in a subject.